These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 21507835)

  • 1. Clinical experience of linezolid in bone marrow transplantation patients.
    Hogan HL; Hachem RY; Neuhauser M; Raad II; Coyle E
    J Pharm Pract; 2010 Aug; 23(4):352-7. PubMed ID: 21507835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retrospective cohort chart review study of factors associated with the development of thrombocytopenia in adult Japanese patients who received intravenous linezolid therapy.
    Niwa T; Suzuki A; Sakakibara S; Kasahara S; Yasuda M; Fukao A; Matsuura K; Goto C; Murakami N; Itoh Y
    Clin Ther; 2009 Oct; 31(10):2126-33. PubMed ID: 19922883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Linezolid does not increase the risk of thrombocytopenia in patients with nosocomial pneumonia: comparative analysis of linezolid and vancomycin use.
    Nasraway SA; Shorr AF; Kuter DJ; O'Grady N; Le VH; Cammarata SK
    Clin Infect Dis; 2003 Dec; 37(12):1609-16. PubMed ID: 14689341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of linezolid in liver transplant patients.
    Radunz S; Juntermanns B; Kaiser GM; Treckmann J; Mathe Z; Paul A; Saner FH
    Transpl Infect Dis; 2011 Aug; 13(4):353-8. PubMed ID: 21355969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombocytopenia associated with linezolid therapy.
    Attassi K; Hershberger E; Alam R; Zervos MJ
    Clin Infect Dis; 2002 Mar; 34(5):695-8. PubMed ID: 11803505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Linezolid-associated thrombocytopenia.
    Lam S
    Consult Pharm; 2012 Jul; 27(7):504-8. PubMed ID: 22910131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hematologic effects of linezolid in young children.
    Meissner HC; Townsend T; Wenman W; Kaplan SL; Morfin MR; Edge-Padbury B; Naberhuis-Stehouwer S; Bruss JB
    Pediatr Infect Dis J; 2003 Sep; 22(9 Suppl):S186-92. PubMed ID: 14520145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors for anaemia in patients on prolonged linezolid therapy for chronic osteomyelitis: a case-control study.
    Senneville E; Legout L; Valette M; Yazdanpanah Y; Giraud F; Beltrand E; Obert G; Dubreuil L; Migaud H; Mouton Y
    J Antimicrob Chemother; 2004 Oct; 54(4):798-802. PubMed ID: 15329363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Linezolid: low pre-treatment platelet values could increase the risk of thrombocytopenia.
    Grau S; Morales-Molina JA; Mateu-de Antonio J; Marín-Casino M; Alvarez-Lerma F
    J Antimicrob Chemother; 2005 Aug; 56(2):440-1. PubMed ID: 15956097
    [No Abstract]   [Full Text] [Related]  

  • 10. Hematologic safety profile of linezolid in the early periengraftment period after allogeneic stem cell transplantation.
    Cohen N; Mihu CN; Seo SK; Chung D; Chou J; Heller G; Papanicolaou GA
    Biol Blood Marrow Transplant; 2009 Oct; 15(10):1337-41. PubMed ID: 19747643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of linezolid compared with vancomycin in a randomized, double-blind study of febrile neutropenic patients with cancer.
    Jaksic B; Martinelli G; Perez-Oteyza J; Hartman CS; Leonard LB; Tack KJ
    Clin Infect Dis; 2006 Mar; 42(5):597-607. PubMed ID: 16447103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Similar hematologic effects of long-term linezolid and vancomycin therapy in a prospective observational study of patients with orthopedic infections.
    Rao N; Ziran BH; Wagener MM; Santa ER; Yu VL
    Clin Infect Dis; 2004 Apr; 38(8):1058-64. PubMed ID: 15095207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparative evaluation of adverse platelet outcomes among Veterans' Affairs patients receiving linezolid or vancomycin.
    Patel N; VanDeWall H; Tristani L; Rivera A; Woo B; Dihmess A; Li HK; Smith R; Lodise TP
    J Antimicrob Chemother; 2012 Mar; 67(3):727-35. PubMed ID: 22174041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Linezolid versus vancomycin for the treatment of infections caused by methicillin-resistant Staphylococcus aureus in Japan.
    Kohno S; Yamaguchi K; Aikawa N; Sumiyama Y; Odagiri S; Aoki N; Niki Y; Watanabe S; Furue M; Ito T; Croos-Dabrera R; Tack KJ
    J Antimicrob Chemother; 2007 Dec; 60(6):1361-9. PubMed ID: 17913720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Case report: severe thrombocytopenia].
    Sakka SG; Schürmann A; Knüttgen D; Wappler F
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2009 Apr; 44(4):242-5. PubMed ID: 19367527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High frequency of linezolid-associated thrombocytopenia among patients with renal insufficiency.
    Lin YH; Wu VC; Tsai IJ; Ho YL; Hwang JJ; Tsau YK; Wu CY; Wu KD; Hsueh PR
    Int J Antimicrob Agents; 2006 Oct; 28(4):345-51. PubMed ID: 16935472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Linezolid use for treatment of multidrug-resistant and extensively drug-resistant tuberculosis, New York City, 2000-06.
    Anger HA; Dworkin F; Sharma S; Munsiff SS; Nilsen DM; Ahuja SD
    J Antimicrob Chemother; 2010 Apr; 65(4):775-83. PubMed ID: 20150181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High frequency of linezolid-associated thrombocytopenia and anemia among patients with end-stage renal disease.
    Wu VC; Wang YT; Wang CY; Tsai IJ; Wu KD; Hwang JJ; Hsueh PR
    Clin Infect Dis; 2006 Jan; 42(1):66-72. PubMed ID: 16323094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. No effect of pyridoxine on the incidence of myelosuppression during prolonged linezolid treatment.
    Plachouras D; Giannitsioti E; Athanassia S; Kontopidou F; Papadopoulos A; Kanellakopoulou K; Giamarellou H
    Clin Infect Dis; 2006 Nov; 43(9):e89-91. PubMed ID: 17029128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Linezolid compared with teicoplanin for the treatment of suspected or proven Gram-positive infections.
    Wilcox M; Nathwani D; Dryden M
    J Antimicrob Chemother; 2004 Feb; 53(2):335-44. PubMed ID: 14729745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.